BRAINTREE, Mass., Nov. 13, 2023 – Microbot Medical Inc., a leading developer of advanced medical devices, has announced the successful completion of the Electromagnetic Compatibility (EMC) testing phase of its innovative LIBERTY® Robotic Surgical System. This milestone marks a significant step forward in Microbot’s efforts to bring its cutting-edge surgical robot to clinical trials.
EMC testing is a crucial part of the overall Verification and Validation (V&V) process. V&V procedures are designed to ensure that a product, service, or system meets specific requirements and fulfills its intended purpose effectively. With the EMC testing now complete, Microbot has demonstrated its commitment to maintaining the highest standards of quality and safety for the LIBERTY system.
In addition to the successful EMC testing, Microbot recently finished a pre-clinical pivotal study, another essential component of its Investigational Device Exemption (IDE) submission to the FDA. Together, these achievements pave the way for the initiation of clinical trials and the necessary regulatory clearance.
Microbot’s CTO & GM, Simon Sharon, expressed his confidence in the company’s progress, stating, “The completion of the EMC testing in our V&V process reinforces our dedication to upholding the highest quality and safety standards for the LIBERTY Robotic Surgical System. Moving forward, we are focused on completing the additional testing required by the V&V process to commence our first clinical trial in the US.”
The LIBERTY Robotic Surgical System is a transformative technology that aims to improve clinical outcomes for patients while enhancing accessibility within the human body. By eliminating the need for large and expensive capital equipment, the LIBERTY system offers a more cost-effective and efficient solution for endovascular procedures. It also reduces radiation exposure for both patients and physicians and minimizes physical strain on medical professionals.
Microbot Medical is a pre-clinical medical device company specializing in micro-robotic technologies. Its mission is to revolutionize surgical robotics and democratize endovascular interventional procedures. More information about Microbot Medical can be found on their website at [www.microbotmedical.com](http://www.microbotmedical.com).
FAQs:
1. What is the purpose of the EMC testing phase?
EMC testing is conducted to ensure that a product or system is not affected by electromagnetic interference and remains functional and safe.
2. What is the significance of completing the V&V process?
Completion of the Verification and Validation (V&V) process demonstrates that a product, service, or system meets specific requirements and is ready for further development or deployment.
3. How does the LIBERTY Robotic Surgical System improve endovascular procedures?
The LIBERTY system eliminates the need for large and cumbersome capital equipment, reduces radiation exposure, and minimizes physical strain on physicians, making endovascular procedures more accessible and efficient.
Sources:
– Microbot Medical Inc. [www.microbotmedical.com](http://www.microbotmedical.com)
– SEC – Securities and Exchange Commission [www.sec.gov](http://www.sec.gov)